Figure 1 is used throughout the 'Methods' section as a graphical reference for analytical discussion.
Method D is the graphical reference tissue model with a cerebellum time-activity curve.
We obtained also direct estimates of binding potentials using a graphical reference tissue model and two nonlinear reference tissue models.
In addition, the values obtained by the graphical plasma input model correlated significantly with those obtained by the graphical reference tissue model and the simplified reference tissue model.
The graphical plasma input method and the graphical reference tissue method provided estimates of the binding potential that correlated closely, but differed in magnitude.
The values obtained by the single-tissue compartment model (i.e., method A) correlated significantly with those obtained by the graphical plasma input model and the graphical reference tissue model (i.e., methods C and D, respectively).
The graphical reference of this group wants to provide the reader with a visual comparison between the functional outcome of the three groups under study and the classical reference group of THA patients with an isolated and unilateral hip disease and no other condition affecting mobility and motion.
No statistically significant differences should be observed between the test antihistamine and placebo 3. Various methods of PET imaging with radiolabelled [C]-doxepin have been used successfully for quantification of H1RO; for example, a simplified reference tissue model approach and Logan graphical analysis with reference tissue or arterial sampling 9– 12.
It is to be noted that equations 16, 17 have been derived independent of any graphical representations or reference frames, and they are functions of the instantaneous values of the base counts only.
Referenced graphical media are automatically embedded into these XML files using Base64 encoding.
The SRTM and reference Logan graphical analysis with cerebellum grey matter as reference region were applied to the regional TACs to estimate the BPND, used to quantify the amount of tracer binding to the target proteins.
